BPG is committed to discovery and dissemination of knowledge
Articles in Press
8/24/2019 4:48:02 AM | Browse: 190 | Download: 322
Publication Name World Journal of Gastroenterology
Manuscript ID 49837
Country China
Category Gastroenterology & Hepatology
Manuscript Type Basic Study
Article Title CARMA3/NF-κB signaling contributes to the tumorigenesis of hepatocellular carcinoma and is inhibited by Sodium Aescinate
Manuscript Source Unsolicited Manuscript
All Author List Hui Hou, Wei-Xiang Li, Xiao Cui, Da-Chen zhou, Bin Zhang and Xiao-Ping Geng
Funding Agency and Grant Number
Funding Agency Grant Number
Nature Science Foundation of High Education Institution of Anhui Province KJ2017A825
Natural Science Foundation of Anhui Province 1808085MH270
Foundation of the Higher Education Institution of Henan Province 16A320007
“Huohua Jihua” Foundation of the Second Hospital of Anhui Medical University Science No.2015hhjh05
Anhui Medical University Science Foundation 2017xkj033
Corresponding Author Xiao-Ping Geng, MD, Director, Professor, Department of Hepato-Pancreato-Biliary Surgery, Department of Surgery,, The First Affiliated Hospital of Anhui Medical University, No. 120 Wanshui Road, Gaoxin District, Hefei 230032, Anhui Province, China. xp_geng@163.net
Key Words CARMA3; Nuclear factor kappa-B; Sodium Aescinate; Hepatocellular carcinoma; Tumorigenesis; Liver cancer
Core Tip Hepatocellular carcinoma (HCC) ranked the sixth in the most common malignant tumors and is the most frequent primary liver cancer; nuclear factor kappa-B (NF-κB) signal pathway is commonly activated and exerts critical roles in the progression of HCC. Here, we hypothesized CARMA3 might play an oncogenic role in HCC by activating NF-κB, and explored the relationships between CARMA3 expression and clinicopathological characters. Furthermore, we found Sodium Aescinate, exerted anti-tumor effects possibly by inactivating CARMA3/NF-κB signaling.
Citation Hou H, Li WX, Cui X, Zhou DC, Zhang B, Geng XP. CARMA3/NF-κB signaling contributes to the tumorigenesis of hepatocellular carcinoma and is inhibited by Sodium Aescinate. World J Gastroenterol 2019; 25(36): 5483-5493
Received
2019-06-17 00:21
Peer-Review Started
2019-06-18 02:25
To Make the First Decision
2019-08-05 02:27
Return for Revision
2019-08-07 00:25
Revised
2019-08-13 14:42
Second Decision
2019-08-23 10:09
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2019-08-24 04:48
Articles in Press
2019-08-24 04:48
Publication Fee Transferred
Edit the Manuscript by Language Editor
2019-09-09 22:26
Typeset the Manuscript
2019-09-27 07:26
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com